- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about AMGN
Recent news which mentions AMGN
QUALCOMM, AIG And 2 Other Stocks Insiders Are Selling
August 14, 2023
From Benzinga
Nasdaq Suffers Second Straight Week of Losses, Breaks Key Support Level As Tech Bears Return: Is This Time Different?
August 11, 2023
From Benzinga
The 3 Best Biotech Stocks to Buy in August
August 09, 2023
From InvestorPlace
3 Biotech Stocks You’ll Regret Not Buying Soon
August 08, 2023
From InvestorPlace
Is AbbVie Still a Good Dividend Stock to Buy?
August 08, 2023
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
August 07, 2023
From Benzinga
From Benzinga
Tickers
AMGN
From Motley Fool
Amgen Raises FY23 Outlook, Discloses Brief Readout From Tarlatamab Lung Cancer, Lumakras Colorectal Cancer Studies
August 04, 2023
Tickers
AMGN
From Benzinga
Amgen stock jumps after record earnings beat expectations, and biotech raises full-year outlook
August 03, 2023
From MarketWatch
Why Is Regeneron Pharmaceuticals Moving Higher Today?
August 03, 2023
From Benzinga
3 Dividend Stocks That Hiked Payouts by 60% in Just 5 Years
August 03, 2023
From Motley Fool
US Stock Futures Dip As Apple, Amazon Earnings Loom: Analyst Warns Of 'Perfectly Normal' 5% Pullback This Month
August 03, 2023
From Benzinga
From Benzinga
From Benzinga
Reata's Acquisition Fits Biogen's Strategy Despite High Cost: Analyst Says High Level Regulatory Scrutiny Not Anticipated
July 28, 2023
From Benzinga
From Motley Fool
AbbVie's Skyrizi Achieves Superiority Versus Amgen's Drug In Head-to-Head Study In Moderate Plaque Psoriasis
July 26, 2023
From Benzinga
Seven Humira Biosimilars: Increased Competition In Arthritis Drug Market Sparks Need For Reform Of Drug Pricing Intermediaries
July 26, 2023
From Benzinga
2 Cheap High-Yield Dividend Stocks to Buy Now
July 25, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.